RxDoctor Payments DataLook up a doctor →

Mary Mattei

Women's Health · Mobile, ALNPI 1619251568

Payments from drug & device makers

$9,949in general payments, 2019–2025

Across 452 payments — averaging $22.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Diagnostics Corporation$2K
  • Eisai Inc.$1K
  • Johnson & Johnson$766
  • Regeneron Healthcare Solutions, Inc.$744
  • Novartis$593
  • Daiichi Sankyo Inc.$547
  • plus $4K from 48 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Roche Diagnostics Corporation1$1,800
Eisai Inc.51$1,003
Johnson & Johnson47$766
Regeneron Healthcare Solutions, Inc.36$744
Novartis32$593
Daiichi Sankyo Inc.31$547
AstraZeneca(2 entities)31$529
Merck32$462
Incyte Corporation19$324
GSK13$291
Sanofi13$239
Pfizer10$205
Tersera Therapeutics LLC9$205
Takeda Pharmaceuticals U.S.A., Inc.9$187
Genentech USA, Inc.10$175
Seagen Inc.4$138
Pharmaessentia USA Corporation7$128
Exelixis Inc.6$123
Amgen7$108
Pharmacosmos Therapeutics Inc.6$108
Beigene USA, Inc.5$83
AbbVie4$82
Taiho Oncology, Inc.5$80
Bayer4$72
Stemline Therapeutics Inc.4$68
Sobi, Inc4$67
Lilly USA, LLC4$63
Genmab U.S., Inc.4$62
Boehringer Ingelheim3$53
Blueprint Medicines Corporation3$52
ADC Therapeutics America, Inc.3$51
Puma Biotechnology, Inc.3$45
Novo Nordisk2$37
Myovant Sciences Inc.3$37
Immunogen, Inc.2$32
Deciphera Pharmaceuticals Inc.2$31
Servier Pharmaceuticals LLC2$30
Morphosys, US Inc.2$30
Karyopharm Therapeutics Inc.2$29
Cumberland Pharmaceuticals, Inc.2$29
EMD Serono, Inc.2$28
Array Biopharma Inc1$20
Ipsen Biopharmaceuticals, Inc1$19
Mirati Therapeutics, Inc.1$19
Gilead1$18
Immunocore Limited1$18
Corcept Therapeutics1$17
Caris MPI, Inc.1$17
AVEO Pharmaceuticals, Inc.1$16
Beone Medicines USA, Inc.1$15
Myriad Genetic Laboratories, Inc.1$14
Agios Pharmaceuticals, Inc.1$14
Spectrum Pharmaceuticals Inc.1$13
Coherus Oncology, Inc.1$12

How this compares

$9,949 in reported general payments places this provider in the 95th percentile of 107 women's health providers in Alabama.

See all women's health providers in Alabama →

Medicare billing

Part B allowed, 2024
$10,563
Medicare patients
79
Services billed
164

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other women's health in Mobile

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →